Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,791 | 69 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $866.20 | 37 | $0 (2024) |
| Lilly USA, LLC | $357.81 | 6 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $260.67 | 3 | $0 (2022) |
| GlaxoSmithKline, LLC. | $218.57 | 2 | $0 (2021) |
| Abbott Laboratories | $205.55 | 3 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $190.00 | 2 | $0 (2022) |
| ITI, Inc. | $187.38 | 11 | $0 (2022) |
| Astellas Pharma US Inc | $120.65 | 1 | $0 (2023) |
| Amgen Inc. | $109.14 | 1 | $0 (2024) |
| Axsome Therapeutics, Inc. | $95.00 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $552.32 | 8 | Lilly USA, LLC ($208.38) |
| 2023 | $383.49 | 14 | ABBVIE INC. ($211.39) |
| 2022 | $1,113 | 34 | ABBVIE INC. ($340.52) |
| 2021 | $742.16 | 13 | AbbVie Inc. ($246.40) |
All Payment Transactions
69 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Amgen Inc. | EVENITY (Biological) | Food and Beverage | In-kind items and services | $109.14 | General |
| Category: Bone Health | ||||||
| 10/10/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | Cash or cash equivalent | $95.00 | General |
| Category: Diabetes | ||||||
| 09/19/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | Cash or cash equivalent | $97.20 | General |
| Category: Diabetes | ||||||
| 09/05/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $7.16 | General |
| Category: Diabetes | ||||||
| 06/27/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $71.91 | General |
| Category: Diabetes Care | ||||||
| 05/02/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $95.00 | General |
| Category: Psychology/Psychiatric | ||||||
| 04/24/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $9.02 | General |
| Category: Diabetes | ||||||
| 03/26/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $67.89 | General |
| Category: NEUROSCIENCE | ||||||
| 12/14/2023 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $120.65 | General |
| Category: Biological | ||||||
| 11/09/2023 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $6.95 | General |
| Category: NEUROSCIENCE | ||||||
| 11/09/2023 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $3.76 | General |
| Category: NEUROSCIENCE | ||||||
| 10/12/2023 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $51.45 | General |
| Category: DIABETES CARE | ||||||
| 08/07/2023 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $9.94 | General |
| Category: NEUROSCIENCE | ||||||
| 07/17/2023 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $9.82 | General |
| Category: NEUROSCIENCE | ||||||
| 05/23/2023 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $10.67 | General |
| Category: NEUROSCIENCE | ||||||
| 04/24/2023 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $13.46 | General |
| Category: NEUROSCIENCE | ||||||
| 04/11/2023 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $95.00 | General |
| Category: NEUROSCIENCE | ||||||
| 04/05/2023 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $18.31 | General |
| Category: NEUROSCIENCE | ||||||
| 03/29/2023 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $10.09 | General |
| Category: NEUROSCIENCE | ||||||
| 03/13/2023 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $11.78 | General |
| Category: NEUROSCIENCE | ||||||
| 01/24/2023 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $10.83 | General |
| Category: NEUROSCIENCE | ||||||
| 01/03/2023 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $10.78 | General |
| Category: NEUROSCIENCE | ||||||
| 12/13/2022 | Lilly USA, LLC | — | Food and Beverage | Cash or cash equivalent | $54.43 | General |
| 11/01/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $9.44 | General |
| Category: NEUROSCIENCE | ||||||
| 09/29/2022 | Lilly USA, LLC | EMGALITY (Drug) | Food and Beverage | Cash or cash equivalent | $95.00 | General |
| Category: Neuroscience | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 510 | 779 | $107,678 | $42,080 |
| 2022 | 9 | 620 | 834 | $101,967 | $38,709 |
| 2021 | 11 | 641 | 852 | $113,820 | $45,094 |
| 2020 | 6 | 527 | 786 | $113,817 | $41,856 |
All Medicare Procedures & Services
44 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 230 | 451 | $63,184 | $27,503 | 43.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 34 | 34 | $11,560 | $3,900 | 33.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 60 | 79 | $7,454 | $3,214 | 43.1% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 17 | 17 | $8,585 | $2,487 | 29.0% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2023 | 87 | 112 | $7,952 | $2,439 | 30.7% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 27 | 31 | $3,627 | $1,244 | 34.3% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Facility | 2023 | 11 | 11 | $3,630 | $977.50 | 26.9% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 33 | 33 | $1,334 | $264.33 | 19.8% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 11 | 11 | $352.00 | $51.03 | 14.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 194 | 325 | $41,669 | $18,849 | 45.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 43 | 43 | $14,620 | $4,954 | 33.9% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2022 | 121 | 171 | $12,141 | $4,039 | 33.3% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 77 | 94 | $10,998 | $3,329 | 30.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 59 | 72 | $6,020 | $2,995 | 49.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Facility | 2022 | 16 | 16 | $5,440 | $1,849 | 34.0% |
| 99495 | Transitional care management services for problem of moderate complexity | Facility | 2022 | 15 | 17 | $5,610 | $1,713 | 30.5% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2022 | 14 | 15 | $2,535 | $411.12 | 16.2% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 41 | 41 | $1,558 | $330.90 | 21.2% |
| G0444 | Annual depression screening, 15 minutes | Facility | 2022 | 16 | 16 | $608.00 | $129.44 | 21.3% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2022 | 24 | 24 | $768.00 | $108.88 | 14.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 211 | 345 | $44,298 | $20,367 | 46.0% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 93 | 137 | $15,507 | $6,251 | 40.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Facility | 2021 | 29 | 29 | $9,860 | $3,471 | 35.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 25 | 25 | $8,500 | $2,992 | 35.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 58 | 74 | $6,186 | $2,945 | 47.6% |
About Jennifer Votruba, PA-C
Jennifer Votruba, PA-C is a Physician Assistant healthcare provider based in Pittsfield, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/26/2017. The National Provider Identifier (NPI) number assigned to this provider is 1255851747.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Jennifer Votruba, PA-C has received a total of $2,791 in payments from pharmaceutical and medical device companies, with $552.32 received in 2024. These payments were reported across 69 transactions from 12 companies. The most common payment nature is "Food and Beverage" ($2,791).
As a Medicare-enrolled provider, Votruba has provided services to 2,298 Medicare beneficiaries, totaling 3,251 services with total Medicare billing of $167,739. Data is available for 4 years (2020–2023), covering 44 distinct procedure/service records.
Practice Information
- Specialty Physician Assistant
- Location Pittsfield, MA
- Active Since 06/26/2017
- Last Updated 06/26/2017
- Taxonomy Code 363A00000X
- Entity Type Individual
- NPI Number 1255851747
Products in Payments
- UBRELVY (Drug) $364.70
- QULIPTA (Drug) $303.64
- XARELTO (Drug) $260.67
- TRELEGY ELLIPTA (Drug) $218.57
- VRAYLAR (Drug) $197.86
- CAPLYTA (Drug) $187.38
- FREESTYLE LIBRE 3 (Device) $123.36
- Veozah (Drug) $120.65
- MOUNJARO (Drug) $113.38
- EVENITY (Biological) $109.14
- Auvelity (Drug) $95.00
- BREZTRI (Drug) $95.00
- EMGALITY (Drug) $95.00
- FARXIGA (Drug) $95.00
- JARDIANCE (Drug) $95.00
- DUPIXENT (Biological) $92.45
- FreeStyle Libre 2 (Device) $82.19
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physician Assistant Doctors in Pittsfield
Anita Raj, Pa, PA
Physician Assistant — Payments: $1,693
Mr. Larry Leavitt, Pa, PA
Physician Assistant — Payments: $659.56
Jeffrey Terwilliger, P.a, P.A
Physician Assistant — Payments: $468.61
Colleen Halvorsen-Sinclair, Pa, PA
Physician Assistant — Payments: $420.20
Amanda Accorsi
Physician Assistant — Payments: $267.35
Frank Dawedeit
Physician Assistant — Payments: $262.21